SRI-011381

SRI-011381
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T4283-1mg 1 mg

7 - 10 business days*

30.00€
TGM-T4283-1mL 1 ml

7 - 10 business days*

43.00€
TGM-T4283-5mg 5 mg

7 - 10 business days*

60.00€
TGM-T4283-10mg 10 mg

7 - 10 business days*

106.00€
TGM-T4283-25mg 25 mg

7 - 10 business days*

225.00€
TGM-T4283-50mg 50 mg

7 - 10 business days*

367.00€
TGM-T4283-100mg 100 mg

7 - 10 business days*

550.00€
TGM-T4283-200mg 200 mg

7 - 10 business days*

784.00€
 
Description: SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the... more
Product information "SRI-011381"
Description: SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease. Target: TGF-beta/Smad. Smiles: O=C(NC1CCCCC1)N(CC1CCNCC1)Cc1ccccc1. References: Jingyin Han, et al. The Improvement Effect of Sodium Ferulate on the Formation of Pulmonary Fibrosis in Silicosis Mice Through the Neutrophil Alkaline Phosphatase 3 (NALP3)/Transforming Growth Factor-beta1 (TGF-beta1)/alpha-Smooth Muscle Actin (alpha-SMA) Pathway.
Supplier: TargetMol
Supplier-Nr: T4283

Properties

MW: 329.48 D
Formula: C20H31N3O

Database Information

CAS : 1629138-41-5| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SRI-011381"
Write a review
or to review a product.
Viewed